Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Urothelial Carcinoma”

702 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 702 results

Early research (Phase 1)Study completedNCT00016237
What this trial is testing

Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Bladder CancerKidney CancerLung Cancer
EMD Serono
Not applicableActive Not RecruitingNCT04167631
What this trial is testing

Can VI-RADS/ADC Accurately Stage Bladder Cancer??

Who this might be right for
MRI Contrast Media Adverse ReactionBladder CancerBladder Disease+4 more
Mansoura University 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT03093922
What this trial is testing

Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer

Who this might be right for
Urothelial CarcinomaLocally AdvancedUnresectable
Memorial Sloan Kettering Cancer Center 32
Early research (Phase 1)Study completedNCT02437370
What this trial is testing

Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer

Who this might be right for
Metastatic Urothelial Carcinoma of the Renal Pelvis and UreterRecurrent Bladder CarcinomaRecurrent Urothelial Carcinoma of the Renal Pelvis and Ureter+6 more
University of California, Davis 32
Testing effectiveness (Phase 2)Study completedNCT00794950
What this trial is testing

Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma

Who this might be right for
Urinary Tract Urothelial Carcinoma
University of Michigan 43
Testing effectiveness (Phase 2)Study completedNCT01687244
What this trial is testing

Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
FKD Therapies Oy 40
Testing effectiveness (Phase 2)Looking for participantsNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Not applicableUnknownNCT03577132
What this trial is testing

The Efficacy of Neoadjuvant Atezolizumab Treatment in Patients With Advanced Urothelial Bladder Cancer

Who this might be right for
Urothelial Carcinoma
Seoul National University Hospital 20
Not applicableUnknownNCT05027412
What this trial is testing

En Bloc TURBT With Collins Loop vs Conventional TURBT

Who this might be right for
Bladder CancerBladder NeoplasmBladder Urothelial Carcinoma+2 more
Hospital Universitario de Fuenlabrada 80
Large-scale testing (Phase 3)Study completedNCT02101931
What this trial is testing

A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine

Who this might be right for
Transitional Cell Carcinoma of the Bladder
Princess Al-Johara Al-Ibrahim Cancer Research Center 100
Not applicableStudy completedNCT03013894
What this trial is testing

Confocal Laser Endomicroscopy in the Lower Urinary Tract

Who this might be right for
Bladder NeoplasmUrothelial Carcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 73
Large-scale testing (Phase 3)Ended earlyNCT00191477
What this trial is testing

Instillation of Gemcitabine in Patients With Superficial Bladder Cancer

Who this might be right for
Bladder Neoplasms
Eli Lilly and Company 355
Not applicableEnrolling By InvitationNCT07091565
What this trial is testing

Supporting Sexual Recovery in Women With Bladder Cancer

Who this might be right for
Bladder CancerCystectomyFemale Sexual Dysfunction
King's College London 60
Testing effectiveness (Phase 2)Ended earlyNCT01042795
What this trial is testing

Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy

Who this might be right for
Urothelial CarcinomaBladder Cancer
University of Michigan 7
Early research (Phase 1)Active Not RecruitingNCT05768347
What this trial is testing

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

Who this might be right for
Urothelial CarcinomaNon-Invasive Bladder Urothelial Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 9
Testing effectiveness (Phase 2)UnknownNCT04099589
What this trial is testing

Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma

Who this might be right for
Upper Tract Urinary CarcinomaMuscle-invasive Bladder Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 64
Testing effectiveness (Phase 2)Ended earlyNCT00933374
What this trial is testing

Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma

Who this might be right for
Bladder Cancer
Heinrich-Heine University, Duesseldorf 28
Testing effectiveness (Phase 2)Study completedNCT01551030
What this trial is testing

Buparlisib in Metastatic Transitional Cell Carcinoma of the Urothelium

Who this might be right for
Metastatic Transitional Cell Carcinoma of the Urothelium
Memorial Sloan Kettering Cancer Center 19
Not applicableLooking for participantsNCT06167057
What this trial is testing

POST URS Chemotherapy Instillation

Who this might be right for
UTUC
Carmel Medical Center 264
Early research (Phase 1)Active Not RecruitingNCT06337084
What this trial is testing

Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultBladder CancerUrothelial Carcinoma+6 more
Monopar Therapeutics 12
Next Page